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1. INTRODUCTION {#joa312054-sec-0005}
===============

Catheter ablation of atrial fibrillation (AF) has been performed as an effective treatment for patients with paroxysmal and persistent AF.[1](#joa312054-bib-0001){ref-type="ref"}, [2](#joa312054-bib-0002){ref-type="ref"} Pulmonary vein isolation (PVI) is an essential strategy for AF ablation, and pulmonary vein (PV) reconnections are considered as one of the main causes of recurrence after AF ablation.[3](#joa312054-bib-0003){ref-type="ref"}, [4](#joa312054-bib-0004){ref-type="ref"}

During AF ablation, the location where the ablation is conducted is displayed through annotation tags using a three‐dimensional (3D) system to recognize where the energy delivery was performed in that area. However, manual annotations are usually performed subjectively and we are unable to identify how effectively the ablation has been performed at that location. To remedy this disadvantage, an automated annotation system (VisiTag™ module, Biosense Webster, Inc., Diamond Bar, CA) was recently developed to make an automatic annotation based on predefined criteria, including the catheter stability, contact force (CF), and impedance (IMP) drop. Recent studies using this automated annotation system have demonstrated that an automated annotation based on catheter stability combined with the IMP or CF information has reduced the conduction gaps or reconnections during PVI.[5](#joa312054-bib-0005){ref-type="ref"}, [6](#joa312054-bib-0006){ref-type="ref"}, [7](#joa312054-bib-0007){ref-type="ref"}, [8](#joa312054-bib-0008){ref-type="ref"} The objective of this study was to compare the efficacy of AF ablation between CF‐guided and IMP‐guided annotations using the automated annotation system.

2. METHODS {#joa312054-sec-0006}
==========

2.1. Study population {#joa312054-sec-0007}
---------------------

Fifty patients receiving ablation for paroxysmal or persistent AF were randomly assigned with the same number to two groups with CF‐guided ablation and IMP‐guided ablation. This study protocol was approved by the Institutional Review Board of Keimyung University Dongsan Medical Center (November 11, 2014; DSMC 2014‐10‐052‐001). Informed consent was obtained from all patients.

2.2. Procedure {#joa312054-sec-0008}
--------------

The administration of antiarrhythmic drug (AAD) was stopped for at least five times longer than the half‐life (except for amiodarone). Multislice computed tomography (CT) scans were performed one day before the procedure, and all patients received transesophageal echocardiography prior to the procedure. The ablation procedure was performed under conscious sedation with remifentanil and midazolam.

Three multipolar catheters were inserted through the left femoral region and placed in the right atrium, coronary sinus, and His bundle. Two 8.5 Fr nonsteerable long sheaths (Swartz™ Braided Transseptal Guiding Introducer SL1, St. Jude Medical, St. Paul, MN) were placed in the right atrium through the right femoral region and inserted into the left atrium (LA) using one or two transseptal punctures. After the transseptal puncture, an activated clotting time of over 350 seconds was maintained with intermittent boluses of intravenous heparin. The anatomical structure was identified through LA and PV angiography, and 3D mapping was conducted to map the anatomical structure of the LA and PVs. Then, the prescanned CT and 3D images were merged.

A point‐by‐point ablation was conducted at the junction between the LA and PVs by a circumferential PVI. The PVI was performed with the automated annotation program (VisiTag™ module) using a 3.5 mm irrigated ablation catheter with CF monitoring (THERMOCOOL^®^ SMARTTOUCH™ catheter, Biosense Webster, Inc., Diamond Bar, CA).

The CF‐guided ablation group underwent a PVI guided by automated annotation criteria with a minimum time of 10 seconds, maximum range of 2 mm, CF over a time of 50%, and minimum CF of 10 g. The IMP‐guided ablation group underwent a PVI guided by annotation criteria with a minimum time of 10 seconds, maximum range of 2 mm, and minimum IMP decrease of over 5 Ω instead of the CF parameters. In the IMP‐guided group, the operators were blinded to the contact force data during the PVI. When an automated annotation was not taken even after a repeated energy application delivery, manual tagging was performed at that site and was included for the data analysis.

Ablation was performed in a power‐controlled mode using a power of 30 W for a duration of 25‐30 seconds. Ablation of the posterior wall was performed with a power of 20‐25 W for 15‐20 seconds. A successful PVI was defined by the absence of PV potentials recorded from a 20‐pole circular mapping catheter (LASSO^®^ NAV or LASSO^®^ NAV ECO, Biosense Webster, Inc., Diamond Bar, CA) positioned at each PV ostium. Linear ablation of the cavotricuspid isthmus (CTI) was performed in the patients who had a history of typical atrial flutter. For the patients with persistent AF, the operators routinely performed linear ablation of the CTI. Another additional linear ablation was left to the operator\'s discretion. PV reconnections and dormant conduction were confirmed after a waiting period of 30 minutes. Dormant conduction was assessed for each PV by an intravenous injection of 12 mg of adenosine. Further ablation was performed if there was a PV reconnection or dormant conduction.

2.3. Analysis of the ablation parameters {#joa312054-sec-0009}
----------------------------------------

After the ablation procedure, a data analysis was conducted using the CARTO^®^3 System version 4.3 software. For the analysis, the PVs were divided into 18 segments along the anatomical ablation line (Figure [1](#joa312054-fig-0001){ref-type="fig"}). The data obtained for analysis included the ablation duration, power, average CF, and IMP drop at each point. The data were collected in accordance with the PV segmentation and used for the analysis.

![Segmentation of each pulmonary vein. R = right pulmonary vein, L = left pulmonary vein, RSPV = right superior pulmonary vein, RIPV = right inferior pulmonary vein, LSPV = left superior pulmonary vein, RIPV = right inferior pulmonary vein](JOA3-34-239-g001){#joa312054-fig-0001}

2.4. Follow‐up {#joa312054-sec-0010}
--------------

Antiarrhythmic agents were allowed during the first 3 months of the blanking period, and the maintenance of AADs was left to the physician\'s discretion. An ECG and 24 hour Holter monitoring were obtained right after the procedure and at 3, 6, and 12 months after the ablation. ECG and Holter monitoring were also performed whenever the patient had symptoms suggesting an arrhythmia recurrence. Recurrence of atrial arrhythmias was defined as the detection of AF or atrial tachycardia lasting more than 30 seconds on the ECG or 24 hour Holter monitoring.

2.5. Endpoints {#joa312054-sec-0011}
--------------

The primary endpoint was to compare the success rates of the PVI obtained after creating the initial circumferential ablation line between the two groups. The secondary endpoints were the difference in the values of the ablation parameters and incidence of recurrence of atrial arrhythmias at 1 year between the two groups.

2.6. Statistical analysis {#joa312054-sec-0012}
-------------------------

For the statistical analysis, a Student\'s *t* test or Mann‐Whitney *U* test was used for the comparison of the continuous variables between the two groups and a chi‐square or Fisher\'s exact test was used for the categorical data. Kaplan‐Meier survival estimates were used to compare the degree of recurrence of AF or the incidence of atrial arrhythmias. The data analyses were performed with IBM^®^ SPSS^®^ Statistics version 23 software (IBM Corp., Armonk, NY, USA).

3. RESULTS {#joa312054-sec-0013}
==========

3.1. Patient and procedural characteristics {#joa312054-sec-0014}
-------------------------------------------

The patient clinical characteristics are shown in Table [1](#joa312054-tbl-0001){ref-type="table-wrap"}. There were no significant differences in the baseline characteristics between the CF‐guided and IMP‐guided groups. The average procedure, ablation, and fluoroscopy times revealed no differences between the two groups. Furthermore, there were no differences in the additional ablation strategies between the two groups (Table [2](#joa312054-tbl-0002){ref-type="table-wrap"}).

###### 

Patient characteristics

                           CF‐Guided (n = 25)   IMP‐Guided (n = 25)   *P* value
  ------------------------ -------------------- --------------------- -----------
  Age                      58.5 ± 10.2          56.6 ± 7.7            .467
  Male (%)                 20 (80.0)            20 (80.0)             1.000
  Paroxysmal AF (%)        15 (60.0)            12 (48.0)             .395
  Heart failure (%)        3 (12.0)             1 (4.0)               .609
  Hypertension (%)         12 (48.0)            9 (36.0)              .390
  Diabetes (%)             3 (12.0)             1 (4.0)               .609
  Stroke or TIA (%)        2 (8.0)              1 (4.0)               1.000
  AF duration (mo)         34.7 ± 47.0          31.9 ± 37.8           .942
  CHA~2~DS~2~‐VASc score   1.36 ± 1.32          0.84 ± 1.11           .138
  Ejection fraction (%)    62.7 ± 9.0           61.2 ± 10.6           .682
  LA dimension (cm)        4.23 ± 0.54          4.23 ± 0.52           .973
  LA volume (mL)           85.9 ± 28.4          80.5 ± 28.2           .507

AF, atrial fibrillation; CF, contact force; IMP, impedance; LA, left atrium; TIA, transient ischemic attack.

Data are shown as the mean ± standard deviation or number (%).

John Wiley & Sons, Ltd

###### 

Procedural characteristics

                               CF‐Guided (n = 25)   IMP‐Guided (n = 25)   *P* value
  ---------------------------- -------------------- --------------------- -----------
  Procedure time (min)         201.3 ± 40.4         196.7 ± 23.5          .655
  Ablation time, total (min)   95.3 ± 23.0          90.1 ± 19.4           .446
  Ablation time, PVI (min)     68.7 ± 13.7          73.3 ± 16.5           .294
  Fluoroscopy time (min)       25.5 ± 9.6           26.8 ± 6.5            .603
  Roof line (%)                2 (8.0)              5 (20.0)              .417
  Mitral isthmus line (%)      1 (4.0)              5 (20.0)              .189
  CTI line (%)                 21 (84.0)            21 (84.0)             1.000
  SVC isolation (%)            0 (0.0)              1 (4.0)               1.000
  Complication (%)             0 (0.0)              0 (0.0)               

CF, contact force; CTI, cavotricuspid isthmus; IMP, impedance; PVI, pulmonary vein isolation; SVC, superior vena cava.

Data are shown as the mean ± standard deviation or number (%).

John Wiley & Sons, Ltd

3.2. Pulmonary vein isolation and reconnection data {#joa312054-sec-0015}
---------------------------------------------------

After an initial circumferential ablation line was created, a PVI was achieved in 80% of the patients in the CF‐guided group (20 of 25 patients) and 48.0% of those in the IMP‐guided group (12 of 25 patients) (*P *=* *.018). In terms of each PV, a total of 200 PVs were included. After creating the initial ablation line, 93.0% of the PVs (93/100) in the CF‐guided group and 81% of the PVs (81/100) in the IMP‐guided group were isolated (*P *=* *.012). Among 100 total ipsilateral PV pairs, a successful PVI was obtained in 90% of the ipsilateral PVs (45/50) in the CF‐guided group and 66% (33/50) in the IMP‐guided group (*P *=* *.004) (Figure [2](#joa312054-fig-0002){ref-type="fig"}).

![Success rate of the pulmonary vein isolation after creating the initial circumferential ablation line. PV, pulmonary vein; PVI, pulmonary vein isolation; CF, contact force; IMP, impedance](JOA3-34-239-g002){#joa312054-fig-0002}

All PVs were successfully isolated by additional ablation. After a 30 minute waiting period, 16 patients (32%) had spontaneous pulmonary vein reconnections or dormant conduction without any difference in the incidence between the two groups. The location and number of conduction gaps also showed no differences between the two groups (1.3 ± 1.5 in the CF‐guided group vs 2.24 ± 2.1 in the IMP‐guided group, *P *=* *.096).

3.3. Ablation parameters {#joa312054-sec-0016}
------------------------

The comparison of the ablation parameters between the two groups is shown in Table [3](#joa312054-tbl-0003){ref-type="table-wrap"}. The average CF during the ablation was 12.7 ± 3.2 g in the CF‐guided group and 11.5 ± 2.2 g in the IMP‐guided group without any significant differences (*P *=* *.121). However, the average FTI was significantly higher in the CF‐guided group than IMP‐guided group (298.3 ± 65.2 g·s vs 255.1 ± 38.3 g·s, *P *=* *.007). The average CF was significantly higher at the left upper posterior wall (L1 & L2 segment) in the CF‐guided group. The CF‐guided group also had a significantly higher FTI level in the left posterior roof region (L1 segment). Figure [3](#joa312054-fig-0003){ref-type="fig"} shows the distribution of the CF and FTI at each segment.

###### 

Ablation parameters

                    CF‐Guided (n = 25)   IMP‐Guided (n = 25)   *P* value
  ----------------- -------------------- --------------------- -----------
  CF (g)            12.7 ± 3.2           11.5 ± 2.2            .121
  Time (s)          23.6 ± 1.9           23.0 ± 2.1            .332
  FTI (g·s)         298.3 ± 65.2         255.1 ± 38.3          .007
  IMP drop (Ohms)   7.6 ± 2.9            7.4 ± 1.7             .822

CF, contact force; FTI, force‐time integral; IMP, impedance.

Data are shown as the mean ± standard deviation or number (%).

John Wiley & Sons, Ltd

![Radar chart for the distribution of the contact force (CF, g) (A) and force‐time integral (FTI, g·s) (B) at each segment of the pulmonary vein. L, left pulmonary vein; R = right pulmonary vein; IMP, impedance, \**P *\<* *.05](JOA3-34-239-g003){#joa312054-fig-0003}

3.4. Clinical follow‐up result {#joa312054-sec-0017}
------------------------------

During a 1‐year follow‐up period, one patient in the CF‐guided group experienced a transient ischemic attack without any neurological sequelae. The atrial arrhythmia‐free survival after a single procedure at 1 year with or without AADs demonstrated no difference between the two groups (80.0% in the CF‐guided group vs 84.0% in the IMP‐guided group, *P *=* *.737) (Figure [4](#joa312054-fig-0004){ref-type="fig"}). In total, 34.1% of the patients without arrhythmia recurrences were taking antiarrhythmic medications (35.0% in the CF‐guided group vs 33.3% in the IMP‐guided group). If the use of any AAD beyond the blanking period was considered as a failure even if no AF was documented, the clinical success rate at 1 year was 52.0% for the CF‐guided group vs 56.0% for the IMP‐guided group (*P *=* *.813). The arrhythmia‐free survival rate at 12 months in the patients with paroxysmal AF was 86.7% in the CF‐guided group and 91.7% in the IMP‐guided group (*P *=* *.720). In the persistent AF patients, 70.0% in the CF‐guided group and 76.9% in the IMP‐guided group were free from atrial arrhythmias (*P *=* *.668). No patients received any redo procedures during 1 year of follow‐up.

![Arrhythmia‐free survival curves for atrial arrhythmias](JOA3-34-239-g004){#joa312054-fig-0004}

4. DISCUSSION {#joa312054-sec-0018}
=============

4.1. Main findings {#joa312054-sec-0019}
------------------

The present study demonstrated the following: (i) The PVI using an CF‐guided automated annotation system exhibited higher rates of a successful PVI after an initial circumferential ablation line, (ii) the CF‐guided group had a slightly higher CF value without any clinical significance, but had a significantly higher FTI level as compared to the IMP‐guided ablation, and (iii) the 1 year atrial arrhythmia recurrence rates were similar between the two groups.

4.2. Success rate of the PVI after creating an initial anatomical line {#joa312054-sec-0020}
----------------------------------------------------------------------

Contact force sensing catheters have allowed continuous monitoring of the CF during catheter ablation procedures. Previous studies demonstrated that the lesion size correlated well with the CF,[9](#joa312054-bib-0009){ref-type="ref"}, [10](#joa312054-bib-0010){ref-type="ref"} and PV isolation with a CF sensing catheter reduced any residual conduction gaps and the incidence of PV reconnections.[11](#joa312054-bib-0011){ref-type="ref"}, [12](#joa312054-bib-0012){ref-type="ref"} The present study showed that PV isolation with CF monitoring had a higher success rate of PV isolation after creating an initial circumferential ablation line. Although there was no statistical significance, the CF level was higher in the CF‐guided group than the IMP‐guided group. Because the FTI level is a summation of the CF and duration of the ablation, a nonsignificant higher level of the CF and longer duration of the RF energy delivery might have produced a significantly higher FTI level in the CF‐guided group. Higher FTI values are known to be associated with a durable PVI and better clinical outcomes.[13](#joa312054-bib-0013){ref-type="ref"}, [14](#joa312054-bib-0014){ref-type="ref"}, [15](#joa312054-bib-0015){ref-type="ref"} Therefore, the higher success rate of the PVI in the CF‐guided group might have been caused by the higher values of the FTI in this group.

4.3. Ablation with the automated annotation system {#joa312054-sec-0021}
--------------------------------------------------

The automated annotation system (VisiTag™ module) displays tags automatically when predefined criteria are met. The parameters include the catheter position stability, CF over time, IMP drop, and target temperature. Furthermore, the color of the tag changes based on predefined parameters like the total time, CF, and FTI level.[16](#joa312054-bib-0016){ref-type="ref"}

Stable and constant catheter contact is known to be correlated with the lesion size,[17](#joa312054-bib-0017){ref-type="ref"} but there were have been no tools to evaluate the catheter stability during the catheter ablation procedure. One of the most important pieces of information from the automated annotation system is the real‐time data about the catheter stability during the RF energy delivery. One recent study using the VisiTag™ module reported that the acute success rate of PV isolation was 74% with an automated annotation based on the stability parameters alone, and the addition of CF parameters increased the acute success rate to 92%.[8](#joa312054-bib-0008){ref-type="ref"} Another study[5](#joa312054-bib-0005){ref-type="ref"} showed that ablation using the automated annotation with a combination of stability and IMP criteria had a significantly higher initial success rate of the PV isolation as compared to the traditional manual annotation. Based on the results of these studies, automated annotation based on catheter stability criteria combined with the CF or IMP drop could be considered as a good tool to improve the efficacy of catheter ablation.

Recently, the ablation line contiguity index (ALCI) was introduced as a novel automated algorithm that combines the interlesion distance (contiguity) and measurements of the lesion depth (power, time, and CF).[18](#joa312054-bib-0018){ref-type="ref"} The ablation index (AI) incorporates the CF, power, and time in a weighted formula and overcomes the deficiencies of the FTI by adding information about the power.[19](#joa312054-bib-0019){ref-type="ref"} In addition to the AI, the ALCI provides additional information about the ablation contiguity and the ALCI is an accurate predictor of a durable lesion formation. However, the present study did not include an analysis of the AI and lesion contiguity because the parameters were not commercially available during the study period.

4.4. Impedance changes as a marker for a good contact force {#joa312054-sec-0022}
-----------------------------------------------------------

Before there were CF sensing catheters, the contact between the tissue and ablation catheter could be identified by indirect methods such as a sense of tactile feeling, the size of the local electrogram, and the movement of the catheter tip shown on fluoroscopy. Another surrogate marker for good contact is the IMP changes during radiofrequency energy deliveries. Previous studies reported that a larger IMP decrease during the RF energy delivery was related to a good contact force and an ablation guided by an IMP drop improved the efficacy of the PVI.[5](#joa312054-bib-0005){ref-type="ref"}, [20](#joa312054-bib-0020){ref-type="ref"}, [21](#joa312054-bib-0021){ref-type="ref"}, [22](#joa312054-bib-0022){ref-type="ref"} Although the average FTI level and initial success rate of the PVI were lower, a PVI guided by an IMP drop had a similar CF as that for the CF‐guided ablation in the present study. This result also demonstrated the relationship between the IMP drop and CF and showed the importance of monitoring the IMP changes during the catheter ablation procedure.

The previous study showed that automated annotation guided by an IMP drop of over 5% (\>7‐8 Ω) coupled with catheter stability reduced the conduction recovery and clinical recurrence.[5](#joa312054-bib-0005){ref-type="ref"} In the present study, the IMP‐guided ablation group underwent ablation guided by an annotation criterion with minimum IMP decreases of over 5 Ω (without CF information). In our experience, it took much longer for automated tagging using 10 Ω as the criterion and the annotation was occasionally not taken. Furthermore, the annotation using the 5 Ω criterion used in the present study resulted in a similar IMP drop as compared to the CF‐guided ablation. Therefore, a 5 Ω drop in the IMP could be a reasonable criterion for an automated annotation coupled with the catheter stability criteria.

4.5. Clinical atrial arrhythmia recurrence {#joa312054-sec-0023}
------------------------------------------

Even though the acute success rate was higher in the CF‐guided group, the atrial arrhythmia recurrence rate at 1 year exhibited no differences between the two groups. AF ablation using CF sensing catheters with an optimal contact force had a reduced clinical recurrence of atrial arrhythmias during the follow‐up.[23](#joa312054-bib-0023){ref-type="ref"}, [24](#joa312054-bib-0024){ref-type="ref"}, [25](#joa312054-bib-0025){ref-type="ref"} However, some studies demonstrated no benefit of CF sensing catheters in terms of the clinical AF recurrences.[12](#joa312054-bib-0012){ref-type="ref"}, [26](#joa312054-bib-0026){ref-type="ref"} Ullah et al[12](#joa312054-bib-0012){ref-type="ref"} suggested that an acute improvement in the initial success rate in a CF‐guided ablation is canceled out by further ablation targeting pulmonary reconnections combined with an adenosine injection after a waiting period. In the present study, we also evaluated the PV reconnections and dormant conduction after a 30 minutes waiting period and eliminated any remnant PV conduction. In addition, even though the CF information was blinded, the other group underwent PV isolation guided by an IMP drop with stability monitoring. This could have had a positive impact on reducing the clinical recurrences in the IMP‐guided ablation group. These results imply that AF ablation with real‐time monitoring of a stable catheter position and the additional information of the CF or IMP drop could reduce the clinical recurrences of atrial arrhythmias and improve the clinical outcomes.

4.6. Clinical implications {#joa312054-sec-0024}
--------------------------

Atrial fibrillation ablation with an automated annotation system based on CF and catheter stability criteria is an efficient way to improve the clinical outcomes and preferred technique in our institution. However, CF sensing catheters are not routinely available in clinical practice around the world and there could be a situation we had to use standard catheters. Catheter ablation using an automated annotation based on IMP drop and catheter stability can be used as an alternative method for CF‐guided ablation if CF sensing catheters are not available.

4.7. Limitations {#joa312054-sec-0025}
----------------

Because the primary endpoint of this study was to compare the success rate of an acute PV isolation, the sample size was relatively small and not enough to demonstrate the long‐term clinical outcomes. Even though there were no statistical differences between the two groups, the type of AF included both paroxysmal and persistent AF.

The CF and FTI values were relatively low as compared to the previous reports. In our opinion, the reason for that was because the procedures were performed with nonsteerable sheaths and under conscious sedation without a jet ventilator. Nonetheless, the initial success rate of the PV isolation and 1 year clinical outcome were comparable to the previous studies. Those results suggest that the optimal CF and FTI values might be reevaluated when performing PVI with an automated annotation system that provides real‐time stability monitoring.

The recurrence of atrial arrhythmias was evaluated by ECGs or 24 hour Holter monitoring, and patients who were taking AADs were included in the evaluation. This might have caused an underestimation of the recurrence rate of atrial arrhythmia recurrences during the follow‐up.

5. CONCLUSION {#joa312054-sec-0026}
=============

Contact force ‐guided AF ablation with an automated annotation system improved the acute success rate of the PVI after creating an initial anatomical ablation line as compared to an IMP‐guided ablation. An IMP‐guided annotation combined with catheter stability criteria had a similar atrial arrhythmia‐free survival rate at 1 year as compared to the CF‐guided annotation.
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